CAMILA DAVALOS: Open Payments
NPI 1033849856 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 9 payments from 4 companies in 2025. Trend: 2023 $488 · 2024 $395 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $274 |
| Ethicon US, LLC | 1 | $60 |
| Incyte Corporation | 1 | $17 |
| BeOne Medicines USA, Inc. | 1 | $17 |
Products named: JEMPERLI, Endopath Xcel, NIKTIMVO, TEVIMBRA.
Industry payments across FL — which companies pay providers there.
